Expression of Selected Inflammatory Cytokine Genes in Bladder Biopsies
DOI:
https://doi.org/10.33736/bjrst.247.2013Keywords:
Expression analysis, inflammatory cytokines, bladder biopsiesAbstract
Besides the deregulation of oncogene and tumour suppressor gene, bladder carcinoma can also be caused byinflammation. To date, the association of inflammatory cytokines with carcinoma of the bladder (especially the
transitional cell carcinomas) is not fully understood. In this study, we report an attempt to examine expression
patterns of pro- and anti- inflammatory cytokine genes from normal and tumour tissue biopsies of the human
bladder. Our molecular assays involved the use of the GeneXP™ Human Cyto-3 kit and the Reverse
Transcription – Polymerase Chain Reaction test. Due to limitation in our experimental process, mainly attributed
by inconsistencies in the results obtained between the two assay systems, we cannot reach a conclusion
regarding the association of the six selected inflammatory cytokine genes (IL-8, IL-12A, IL-18, TGF-β1, TGF-
β2, and TGF-β3) with bladder carcinoma. However, our data provided early novel evidence of expression of
four inflammatory cytokine genes, namely IL-12A, TGF-β1, TGF-β2, and TGF-β3 in tissues derived from the
human bladder.
References
Coussens, L.M. & Werb, Z. (2001). Inflammatory cells and cancer: Think Different! Journal of Experimental Medicine, 193(6): F23-F26.
https://doi.org/10.1084/jem.193.6.F23
Inoue, K., Slaton, J.W., Kim, S.J., Perrotte, P., Eve, B.Y., Bar-Eli, M., Radinsky, R., & Dinney, C.P.N. (2000). Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Research, 60: 2290-2299.
https://doi.org/10.1097/00005392-199904010-00483
Lin, W.W. & Karin, M. (2007). A cytokinemediated link between innate immunity, inflammation and cancer. The Journal of Clinical Investigation, 117(5): 1175-1183.
https://doi.org/10.1172/JCI31537
Michaud, D.S. (2007). Chronic inflammation and bladder cancer. Urologic Oncology: Seminars and Original Investigations, 25: 260-268.
https://doi.org/10.1016/j.urolonc.2006.10.002
Thalmann, G.N., Sermier, A., Rentsch, C., Mohrle, K., Cecchini, M.G., & Studer, U.E. (2000). Urinary interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with Bacillus Calmette-Guerin. The Journal of Urology, 164: 2129-2133.
Downloads
How to Cite
Issue
Section
License
Copyright Transfer Statement for Journal
1) In signing this statement, the author(s) grant UNIMAS Publisher an exclusive license to publish their original research papers. The author(s) also grant UNIMAS Publisher permission to reproduce, recreate, translate, extract or summarize, and to distribute and display in any forms, formats, and media. The author(s) can reuse their papers in their future printed work without first requiring permission from UNIMAS Publisher, provided that the author(s) acknowledge and reference publication in the Journal.
2) For open access articles, the author(s) agree that their articles published under UNIMAS Publisher are distributed under the terms of the CC-BY-NC-SA (Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work of the author(s) is properly cited.
3) For subscription articles, the author(s) agree that UNIMAS Publisher holds copyright, or an exclusive license to publish. Readers or users may view, download, print, and copy the content, for academic purposes, subject to the following conditions of use: (a) any reuse of materials is subject to permission from UNIMAS Publisher; (b) archived materials may only be used for academic research; (c) archived materials may not be used for commercial purposes, which include but not limited to monetary compensation by means of sale, resale, license, transfer of copyright, loan, etc.; and (d) archived materials may not be re-published in any part, either in print or online.
4) The author(s) is/are responsible to ensure his or her or their submitted work is original and does not infringe any existing copyright, trademark, patent, statutory right, or propriety right of others. Corresponding author(s) has (have) obtained permission from all co-authors prior to submission to the journal. Upon submission of the manuscript, the author(s) agree that no similar work has been or will be submitted or published elsewhere in any language. If submitted manuscript includes materials from others, the authors have obtained the permission from the copyright owners.
5) In signing this statement, the author(s) declare(s) that the researches in which they have conducted are in compliance with the current laws of the respective country and UNIMAS Journal Publication Ethics Policy. Any experimentation or research involving human or the use of animal samples must obtain approval from Human or Animal Ethics Committee in their respective institutions. The author(s) agree and understand that UNIMAS Publisher is not responsible for any compensational claims or failure caused by the author(s) in fulfilling the above-mentioned requirements. The author(s) must accept the responsibility for releasing their materials upon request by Chief Editor or UNIMAS Publisher.
6) The author(s) should have participated sufficiently in the work and ensured the appropriateness of the content of the article. The author(s) should also agree that he or she has no commercial attachments (e.g. patent or license arrangement, equity interest, consultancies, etc.) that might pose any conflict of interest with the submitted manuscript. The author(s) also agree to make any relevant materials and data available upon request by the editor or UNIMAS Publisher.
